882 related articles for article (PubMed ID: 18199639)
21. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
22. Protection of mice against the highly pathogenic VV
Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
[TBL] [Abstract][Full Text] [Related]
23. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
Perera LP; Waldmann TA; Mosca JD; Baldwin N; Berzofsky JA; Oh S
J Virol; 2007 Aug; 81(16):8774-83. PubMed ID: 17553867
[TBL] [Abstract][Full Text] [Related]
24. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
Viner KM; Isaacs SN
Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
[TBL] [Abstract][Full Text] [Related]
25. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
Pacchioni SM; Bissa M; Zanotto C; Morghen Cde G; Illiano E; Radaelli A
J Transl Med; 2013 Apr; 11():95. PubMed ID: 23578094
[TBL] [Abstract][Full Text] [Related]
26. A novel, killed-virus nasal vaccinia virus vaccine.
Bielinska AU; Chepurnov AA; Landers JJ; Janczak KW; Chepurnova TS; Luker GD; Baker JR
Clin Vaccine Immunol; 2008 Feb; 15(2):348-58. PubMed ID: 18057181
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
[TBL] [Abstract][Full Text] [Related]
28. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulator-based enhancement of anti smallpox immune responses.
Martínez O; Miranda E; Ramírez M; Santos S; Rivera C; Vázquez L; Sánchez T; Tremblay RL; Ríos-Olivares E; Otero M
PLoS One; 2015; 10(4):e0123113. PubMed ID: 25875833
[TBL] [Abstract][Full Text] [Related]
30. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
Braxton CL; Puckett SH; Mizel SB; Lyles DS
J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
[TBL] [Abstract][Full Text] [Related]
31. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
32. Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein.
Adamo JE; Meseda CA; Weir JP; Merchlinsky MJ
J Gen Virol; 2009 Nov; 90(Pt 11):2604-2608. PubMed ID: 19587131
[TBL] [Abstract][Full Text] [Related]
33. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
[TBL] [Abstract][Full Text] [Related]
34. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.
Kidokoro M; Tashiro M; Shida H
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4152-7. PubMed ID: 15753319
[TBL] [Abstract][Full Text] [Related]
35. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
[TBL] [Abstract][Full Text] [Related]
37. Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies.
Rauthan M; Kaur R; Appaiahgari MB; Vrati S
Microbes Infect; 2004 Nov; 6(14):1305-11. PubMed ID: 15555537
[TBL] [Abstract][Full Text] [Related]
38. Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models.
Kumar A; Yogisharadhya R; Venkatesan G; Bhanuprakash V; Pandey AB; Shivachandra SB
Antiviral Res; 2017 May; 141():174-178. PubMed ID: 28259752
[TBL] [Abstract][Full Text] [Related]
39. [Development of a numerically additive combined vaccine against tetanus and smallpox].
Mayr A; Baljer G; Wagner C; Sailer J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
[TBL] [Abstract][Full Text] [Related]
40. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
